Clinical Trials Browser

OTHER × Doxorubicin × Genitourinary × Clear all

NCT05137262 2026-02-18

A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder

Phase 2 Active not recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06630325 2026-01-07

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Phase 2 Active not recruiting

GastrointestinalGenitourinaryGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT02420847 2025-11-10

Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery

Phase 1/2 Active not recruiting

Carcinoma, Transitional Cell

NCT00479128 2025-10-28

Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors

Phase 1 Active not recruiting

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT04383743 2025-09-18

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Phase 2 Completed

17 enrolled 12 charts

Urinary Bladder Neoplasms

NCT03878524 2024-03-04

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Phase 1 Terminated

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT03912818 2023-09-11

Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer

Phase 2 Terminated

7 enrolled 9 charts

GenitourinarySarcoma

Bladder Adenocarcinoma

NCT00003683 2021-02-21

Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00478361 2020-10-09

Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function

Phase 2 Completed

40 enrolled 7 charts

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT03892330 2019-03-27

Combination Therapy of Anthracyclines for Children With Nephroblastoma

Phase 4 Not yet recruiting

Wilms Tumor

NCT02560051 2018-11-28

Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer

Phase 2 Terminated

19 enrolled 25 charts

Prostatic Neoplasms

NCT02494713 2018-11-27

Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer

Phase 2 Terminated

4 enrolled 16 charts

Prostatic Neoplasms

NCT00002855 2018-10-31

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00080782 2018-10-31

Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases

Phase 2 Terminated

Neoplasm Metastasis, Prostatic Neoplasms

NCT02214602 2018-03-22

NMIBCIVT

Phase 4 Completed

Non-Muscle Invasive Bladder Neoplasms

NCT00630409 2017-03-10

Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma

Phase 2 Completed

5 enrolled 2 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00416533 2017-01-19

Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2 Completed

Prostatic Neoplasms

NCT00081159 2016-11-10

Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases

Phase 2 Completed

80 enrolled 6 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT00808639 2016-10-24

Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma

Phase 2 Completed

39 enrolled 7 charts

Urinary Bladder Neoplasms

NCT00014534 2016-07-14

Combination Chemotherapy in Treating Patients With Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms

NCT00003682 2016-06-23

Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer

Phase 3 Terminated

Prostatic Neoplasms

NCT00506155 2016-03-31

Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer

Phase 2 Completed

60 enrolled 10 charts

Urinary Bladder Neoplasms

NCT00024167 2016-03-22

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Phase 3 Terminated

265 enrolled 9 charts

Prostatic Neoplasms

NCT00635726 2015-10-08

Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer

Phase 2 Terminated

Urinary Bladder Neoplasms

NCT00176293 2015-04-21

Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer

Phase 2 Terminated

Neoplasm Metastasis, Prostatic Neoplasms

NCT00002721 2014-05-21

Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT00002919 2013-07-03

Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms

NCT00003105 2013-07-03

Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer

Phase 1/2 Completed

Urinary Bladder Neoplasms

NCT00003133 2013-06-28

Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer

Phase 1 Completed

Urinary Bladder Neoplasms

NCT01095926 2013-06-28

Doxo

Phase 2 Completed

CNSGenitourinaryLymphoidOther hematologic neoplasmSarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Sarcoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Cardiotoxicity

NCT00002466 2013-06-20

Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer

Phase 2 Completed

GenitourinarySarcoma

Askin Tumor, Kidney Neoplasms, Wilms Tumor, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

NCT00014352 2013-01-16

Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms, Thromboembolism

NCT00080795 2012-10-22

Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium

Phase 2 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00003084 2012-07-30

Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00003038 2011-08-03

Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

BreastEndocrineGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Adrenocortical Carcinoma